Keyphrases
Acute Myeloid Leukemia
100%
Allogeneic
14%
Allogeneic Bone Marrow Transplantation
18%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
92%
Allogeneic Peripheral Blood Stem Cell Transplantation
12%
AMD3100
17%
Autologous Transplantation
15%
Bone Marrow
15%
C-X-C Chemokine Receptor Type 4 (CXCR4)
15%
Cancer Genome Atlas
17%
Cancer Types
23%
CD34+
12%
CD34+ Cells
21%
Chemotherapy
19%
Chimeric Antigen Receptor T Cells (CAR-T)
15%
Chronic Myeloid Leukemia
20%
Complete Remission
16%
Confidence Interval
17%
Cytarabine
13%
Decitabine
12%
Engraftment
16%
Graft-versus-host Disease (GvHD)
65%
Granulocyte Colony-stimulating Factor (G-CSF)
81%
Hematological Malignancies
21%
Hematopoietic Cell Transplantation
20%
Hematopoietic Stem Cell Mobilization
21%
Hematopoietic Stem Cell Transplantation
17%
Hematopoietic Stem Cells
40%
Leukemia
26%
Marrow
12%
Multiple Myeloma
47%
Myelodysplastic Syndrome
39%
Neutrophils
13%
Non-Hodgkin Lymphoma
24%
Overall Survival
21%
Peripheral Blood
23%
Phase II Study
20%
Placebo
16%
Plerixafor
30%
Relapsed or Refractory
21%
Relapsed or Refractory Acute Myeloid Leukemia
15%
Ruxolitinib
12%
Stem Cell Mobilization
21%
Stem Cell Transplantation
13%
Stem Cells
21%
T Cells
26%
Total Body Irradiation
11%
Transplantation
27%
Tumor
25%
Unrelated Donor
16%
Immunology and Microbiology
Acute Graft Versus Host Disease
23%
Allogeneic Bone Marrow Transplantation
7%
Allogeneic Stem Cell Transplantation
10%
Allotransplantation
8%
Apheresis
8%
Autologous Stem Cell Transplantation
11%
Autotransplantation
11%
B Cell
7%
Bone Marrow Transplantation
8%
CD34
40%
Cell Line
7%
Cell Transplantation
40%
Chronic Graft Versus Host Disease
11%
Conditioning
19%
CXCR4
15%
Cyclophosphamide
16%
Cytokine
11%
Cytomegalovirus
8%
Disease Free Survival
6%
Drug Megadose
19%
Engraftment
22%
Graft-Versus-Host Disease
42%
Granulocyte
9%
Granulocyte Colony-Stimulating Factor
40%
Granulocyte Macrophage Colony-Stimulating Factor
21%
Granulocyte Macrophage Colony-Stimulating Factor Receptor
7%
Hematopoietic Cell
44%
Hematopoietic Stem Cell
37%
Hematopoietic Stem Cell Transplantation
17%
Immunotherapy
10%
Leukemia Cell
14%
Lymphocyte
7%
Mouse
18%
Mouse Model
9%
Multiple Myeloma
38%
Myeloid
56%
Natural Killer Cell
11%
Neutrophil
7%
Neutrophil Granulocyte
10%
Overall Survival
16%
Peripheral Blood Stem Cell
15%
Platelet
9%
Plerixafor
34%
Regulatory T Cell
8%
Stem Cell
37%
Stem Cell Transplant
16%
Stem Cell Transplantation
7%
T Cell
40%
Transplant Procedure
40%
Tumor Cell
8%
Medicine and Dentistry
Acute Graft Versus Host Disease
12%
Acute Myeloid Leukemia
57%
Allogeneic Stem Cell Transplantation
12%
Allogenic Bone Marrow Transplantation
8%
Apheresis
8%
Autologous Stem Cell Transplantation
12%
Autotransplantation
8%
Bone Marrow Transplantation
7%
Cancer Types
9%
Cell Transplantation
30%
Chimeric Antigen Receptor T-Cell
10%
Chronic Myelogenous Leukemia
14%
Conditioning
12%
Cyclophosphamide
9%
Cytokine
8%
Decitabine
9%
Disease
25%
Engraftment
11%
Graft Versus Host Reaction
19%
Granulocyte
8%
Granulocyte Colony Stimulating Factor
34%
Granulocyte Macrophage Colony Stimulating Factor
8%
Hematologic Malignancy
16%
Hematopoietic Stem Cell
37%
Hematopoietic Stem Cell
25%
Hematopoietic Stem Cell Transplantation
19%
Immunotherapy
9%
Leukemia
13%
Leukemia Cell
11%
Malignant Neoplasm
22%
Multiple Myeloma
26%
Myelodysplastic Syndrome
23%
Neoplasm
25%
Neutrophil
14%
Non-Hodgkin Lymphoma
13%
Overall Survival
16%
Peripheral Blood Stem Cell
9%
Placebo
9%
Platelet
15%
Plerixafor
25%
Progenitor Cell
9%
Receptor
7%
Stem Cell
16%
Stem Cell Mobilization
23%
Stem Cell Therapy
12%
Stem Cell Transplant
14%
T Cell
11%
The Cancer Genome Atlas
8%
Transplantation
31%
Whole Body Radiation
8%